2020
DOI: 10.1016/j.drudis.2020.09.023
|View full text |Cite
|
Sign up to set email alerts
|

Psoriasis: pathological mechanisms, current pharmacological therapies, and emerging drug delivery systems

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
31
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 55 publications
(36 citation statements)
references
References 81 publications
0
31
0
1
Order By: Relevance
“…It affects about 2–3% of the world’s population, with a prevalence of young adults (15–25 years old); moreover, 10–30% of the affected people can also develop psoriasis arthritis at later stages. The rapid reoccurrence and the peculiar appearance may have sociological implications on patients’ everyday lives, thereby causing significant morbidity [ 191 ]. Although governed by the patient’s immune system, the intricate pathophysiology of psoriasis has been attributed to several factors, such as genetic predisposition and environmental triggers (e.g., trauma, emotional stress, infections).…”
Section: Hydroxycinnamic Acids and Derivatives: Activities On Skin Disordersmentioning
confidence: 99%
See 3 more Smart Citations
“…It affects about 2–3% of the world’s population, with a prevalence of young adults (15–25 years old); moreover, 10–30% of the affected people can also develop psoriasis arthritis at later stages. The rapid reoccurrence and the peculiar appearance may have sociological implications on patients’ everyday lives, thereby causing significant morbidity [ 191 ]. Although governed by the patient’s immune system, the intricate pathophysiology of psoriasis has been attributed to several factors, such as genetic predisposition and environmental triggers (e.g., trauma, emotional stress, infections).…”
Section: Hydroxycinnamic Acids and Derivatives: Activities On Skin Disordersmentioning
confidence: 99%
“…In the past decades, various pathogenic mechanisms have been identified, leading to different therapeutic approaches with improved patient compliance and limited adverse effects. Usually, treatments for psoriasis management comprise topical therapy (with vitamin D analogues, corticosteroids, retinoids in the form of gels, creams, and ointments), systemic therapy (with orally delivered immunosuppressants such as methotrexate and cyclosporine), phototherapy, and biological agents (such as monoclonal antibodies, gene therapy, anti-cytokine treatments, anti-T cells therapy, phosphodiesterase 4 inhibitors) [ 191 ].…”
Section: Hydroxycinnamic Acids and Derivatives: Activities On Skin Disordersmentioning
confidence: 99%
See 2 more Smart Citations
“…Epidermal growth describes elongated rete pegs, thickening, and differentiation changes. This pattern of growth is termed as “psoriasiform” hyperplasia (Rapalli et al, 2020).…”
Section: Introductionmentioning
confidence: 99%